ArticleCase reports in pediatrics2026
HYPER-HIE Phenotype: Postrewarming Systemic Hypertension Following Hypoxic-Ischemic Encephalopathy-A Case Report and Mechanistic Review.
Article in Case reports in pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- HYPER-HIE Phenotype: Postrewarming Systemic Hypertension Following Hypoxic-Ischemic Encephalopathy-A Case Report and Mechanistic Review.Case reports in pediatrics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Perinatal asphyxia is frequently complicated by cardiovascular instability. Although hypotension and myocardial dysfunction are widely recognized, systemic hypertension after asphyxia has been described in human neonates and may represent a distinct hemodynamic phenotype. Case Report: We present two infants with hypoxic-ischemic encephalopathy treated with therapeutic hypothermia who developed systemic hypertension following rewarming and received milrinone as part of hemodynamic management. Blood pressure normalized during the recovery phase while the infants were receiving milrinone; however, the observational nature of these cases precludes conclusions regarding treatment efficacy. Review of Literature: We provide a narrative review summarizing the available human evidence for postrewarming systemic hypertension and discuss potential mechanisms, implications for phenotype-directed management, and priorities for future research. Conclusion: These cases suggest the existence of systemic hypertension emerging after therapeutic hypothermia as a distinct postrewarming hemodynamic phenotype (HYPER-HIE phenotype), characterized by elevated systemic vascular resistance despite recovering myocardial function. Recognition of this phenotype has important implications for postrewarming cardiovascular surveillance and phenotype-directed hemodynamic management in neonatal encephalopathy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.